3
Announcements
Trials
Browse
Landscape
Status
Completed
68
Recruiting
24
Terminated
12
Active not recruiting
9
Unknown
6
Withdrawn
3
Not yet recruiting
2
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
70
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Lymphedema
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Anxiety Disorders
3
Uterine Cervical Neoplasms
2
Melanoma
2
Fatigue
2
Depression
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Breast Cancer Metastatic
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tinnitus
1
Thyroid Neoplasms
1
Tension-Type Headache
1
TNBC
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Stenosis
1
Spinal Cord Injuries
1
Small Cell Lung Carcinoma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Kidney Neoplasms
×
Breast
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled